Format

Send to

Choose Destination
Cancer Cell. 2012 Sep 11;22(3):281-2. doi: 10.1016/j.ccr.2012.08.019.

Ready, set, go: the EGF receptor at the pancreatic cancer starting line.

Author information

1
Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Abstract

Acinar-to-ductal metaplasia (ADM) results from pancreatic injury or KRAS activation, and is an early step in pancreatic cancer progression. In this issue of Cancer Cell, Ardito and colleagues and Navas and colleagues demonstrate that ADM- and KRAS-driven pancreatic cancer require EGFR signaling, revealing a mechanism for developmental reprogramming that primes tumorigenesis.

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center